1

2

3

4

5
Guillemont Jerôme Emile Georges, Paugam Mikaël, Delest Bruno François Marie, Heeres Jan, Lewi Paulus Joannes, Janssen Paul Adriaan Jan: Hiv inhibiting bicyclic pyrimidine derivatives. Tibotec Pharmaceuticals, Guillemont Jerôme Emile Georges, Paugam Mikaël, Delest Bruno François Marie, Heeres Jan, Lewi Paulus Joannes, Arts Frank Xavier Jozef Herwig, WANTE Dirk, May 4, 2006: WO/2006/045828 (46 worldwide citation)

HIV replication inhibitors of formula (I) N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a1=a2-a3=a4- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, -N=CH- CH=N-, -N=N-CH=CH-; -b1=b2-b3=b4- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, ...


6

7
Guillemont Jerôme Emile Georges, Heeres Jan, Lewi Paulus Joannes: Hiv inhibiting 5-heterocyclyl pyrimidines. Tibotec Pharmaceuticals, Guillemont Jerôme Emile Georges, Heeres Jan, Lewi Paulus Joannes, WANTE Dirk, April 6, 2006: WO/2006/035067 (11 worldwide citation)

HIV replication inhibitors of formula (I), N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a1=a2-a3=a4- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, -N=N-CH=CH-; -b1=b2-b3=b4- is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, ...


8
Guillemont Jerôme Emile Georges, Heeres Jan, Lewi Paulus Joannes: Hiv inhibiting 5-substituted pyrimidines. Tibotec Pharmaceuticals, Guillemont Jerôme Emile Georges, Heeres Jan, Lewi Paulus Joannes, WANTE Dirk, April 6, 2006: WO/2006/035069 (10 worldwide citation)

HIV replication inhibitors of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein A is -CH2-CH2- , -CH=CH- , -C≡C- ; R1 is hydrogen, aryl, formyl, C1-6alkylcarbonyl, C1-6alkyl, C1-6alkyloxycarbonyl, R2 hydroxy, h ...


9

10
Baert Lieven Elvire Colette, Lewi Paulus Joannes, Heeres Jan: Prevention of hiv- infection with tmc278. Tibotec Pharmaceuticals, Baert Lieven Elvire Colette, Lewi Paulus Joannes, Heeres Jan, WANTE Dirk, October 12, 2006: WO/2006/106103 (3 worldwide citation)

This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals.